A Study of MRG003 in the Treatment of Patients With EGFR-positive Advanced or Metastatic Solid Tumors

NCT05688605 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumors

Interventions

DRUG: MRG003+HX008

Sponsor

Shanghai Miracogen Inc.